You’re right about pharmaceutical shenanigans. A drug used for leukemia in Europe (alemtuzumab) has been affordable until it was discovered it could be used to treat MS. This is not a cure, just a DMT (disease modifying treatment) that is used in hopes that the damage from the disease can be slowed...only one type of MS is approved to take this med, RRMS...relapsing remitting MS.
The company removed it from the market altogether. Renamed it Lemtrada, and provides it to MS patients now. What would have been a $600 yearly cost for the med alemtuzumab, is a $75K per year cost to the MS patient and/or his insurance company for Lemtrada.
Thanks for that info. Very depressing to see this kind of behavior.